As the kickoff to the DYRK1A, related kinases & human disease conference in Saint-Malo, France on November 22nd approaches, the Enzymlogic team is becoming increasingly excited. We are proud to have been selected to give a Podium Presentation highlighting the company’s KINETICfinder® and COVALfinder® technologies.
During the podium presentation, entitled “Hunting for effective drugs with kinetics”, Ana Corrionero, CEO at Enzymlogic, will detail how our platforms enable improved screening of compounds in early discovery: to iterate medicinal chemistry, understand PK/PD disconnects and build better models to define therapeutic windows. Don’t miss the opportunity to join us and learn how our HTS kinetic platforms can bring you and your business great competitive advantage.